3.204

2.36% 0.074

Lyra Therapeutics Inc (LYRA)

Overview News Price History Option Chain Financials Discussions Forecast

Lyra Therapeutics Inc stock is traded at $3.204, with a volume of 4,424. It is up +2.36% in the last 24 hours and down -52.81% over the past month. Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Previous Close:

$3.13

Open:

$3.1035

24h Volume:

4,424

Relative Volume:

0.15

Market Cap:

$5.73M

Revenue:

$770.00K

Net Income/Loss:

$-38.84M

P/E Ratio:

-0.2256

EPS:

-14.2049

Net Cash Flow:

$-43.02M

1W Performance:

-16.78%

1M Performance:

-52.81%

6M Performance:

-31.83%

1Y Performance:

-64.77%

1-Day Range:

$3.1035

$3.24

1-Week Range:

$3.1035

$3.9899

52-Week Range:

$3.1035

$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name

Lyra Therapeutics Inc

Sector

Healthcare (1137)

Industry

Biotechnology (632)

Phone

617-373-4600

Address

480 ARSENAL WAY, WATERTOWN, MA

Employee

Twitter

@LyraTx

Next Earnings Date

2025-03-12

Latest SEC Filings

LYRA's Discussions on Twitter

Compare LYRA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LYRA Lyra Therapeutics Inc	3.23	5.56M	770.00K	-38.84M	-43.02M	-14.20
VRTX Vertex Pharmaceuticals Inc	433.34	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	747.89	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	442.80	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	919.59	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	199.60	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-07-24	Downgrade	BofA Securities	Buy → Underperform
May-07-24	Downgrade	H.C. Wainwright	Buy → Neutral
May-07-24	Downgrade	Jefferies	Buy → Hold
May-06-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-06-23	Resumed	BTIG Research	Buy
Aug-31-23	Initiated	H.C. Wainwright	Buy
May-24-22	Initiated	Cantor Fitzgerald	Overweight
May-26-20	Initiated	BTIG Research	Buy
May-26-20	Initiated	BofA/Merrill	Buy
May-26-20	Initiated	Jefferies	Buy
May-26-20	Initiated	William Blair	Outperform

View All

Lyra Therapeutics Inc Stock (LYRA) Latest News

07:22 AM

Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com

07:22 AM

Nov 20, 2025

Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com

Nov 19, 2025

How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com

Nov 19, 2025

Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com

Nov 19, 2025

How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025

Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025

Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025

What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com

Nov 19, 2025

Nov 18, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com

Nov 18, 2025

Nov 16, 2025

Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com

Nov 16, 2025

Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com

Nov 16, 2025

Nov 15, 2025

Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de

Nov 15, 2025

Nov 14, 2025

PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus

Nov 14, 2025

What indicators show strength in Lyra Therapeutics Inc.2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com

Nov 14, 2025

Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com

Nov 14, 2025

Nov 13, 2025

Major Shareholder Sells Thousands of Lyra Therapeutics Shares! - TipRanks

Nov 13, 2025

BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results - Investing.com Canada

Nov 13, 2025

Nov 12, 2025